Junfang Yang

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang et al. · Blood Advances · 2020 · 215 citations · Full text

Medicine, Hematology, Oncology +14

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia

Xiangyu Zhao, Junfang Yang, Xian Zhang et al. · Molecular Therapy — Oncolytics · 2020 · 126 citations · Full text

Life Sciences, Immunology, Oncology +17

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Junfang Yang, Jiaping He, Xian Zhang et al. · Blood Cancer Journal · 2022 · 100 citations · Full text

Medicine, Hematology, Oncology +17

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Deyan Liu, Ruijuan Sun et al. · Frontiers in Immunology · 2021 · 65 citations · Full text

Medicine, Hematology, Oncology +15

Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo

Jin‐Yuan Ho, Lin Wang, Ying Liu et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 56 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13